Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 12/20 | 0.42 |
| ▸ | SYK | P43405 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16664983 | 0.85 | SYK (0.45) | PIK3CAFAAHSYKCYP1A2CYP3A4 | |
| SCHEMBL15343309 | 0.79 | HCAR3 (0.47) | PIK3CAHRH4FAAH | |
| SCHEMBL15343250 | 0.79 | CYP1A2 (0.50) | PIK3CAHRH4FAAHCYP1A2CYP3A4 | |
| SCHEMBL16660261 | 0.78 | PIK3CA (0.46) | PIK3CAHRH4FAAHCYP1A2CYP3A4 | |
| SCHEMBL16664920 | 0.76 | HRH4 (0.50) | PIK3CAHRH4FAAH | |
| SCHEMBL16660252 | 0.76 | FAAH (0.49) | PIK3CAHRH4FAAH | |
| SCHEMBL17634891 | 0.75 | PRKDC (0.49) | PIK3CAFAAHSYKCYP1A2CYP3A4 | |
| SCHEMBL15343419 | 0.75 | FAAH (0.50) | PIK3CAHRH4FAAHSYK | |
| SCHEMBL15356519 | 0.75 | FAAH (0.48) | PIK3CAHRH4FAAHCYP1A2CYP3A4 | |
| SCHEMBL15473138 | 0.74 | KDM4E (0.49) | PIK3CAHRH4FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015058031-A1 | DNA-PK INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2015-04-23 | — | — | WO | disclosed |